Summary

Creates a new advisory and evidentiary rule tied to federal drug-distribution offenses involving a specified fentanyl analogue that caused a death. It says such offenses can lead to homicide charges, requires courts to advise defendants in those cases that a death occurred, and allows certain prior convictions or sworn plea/acknowledgment statements about those fentanyl-analogue cases to be used as evidence of the defendant’s knowledge in later federal murder or manslaughter prosecutions. The rule does not apply to defendants who were minors when the earlier offense occurred.

• Adds an advisory requirement and evidentiary rule to federal drug law for a specified fentanyl analogue when a death resulted.
• Allows prior convictions or guilty/no-contest pleas tied to such fentanyl-analogue distributions that resulted in death to be used as evidence of knowledge in later federal murder or manslaughter cases.
• Requires courts to advise defendants in qualifying § 841 cases that a death occurred (advisory text referenced but not included).
• Permits substantially similar sworn state-court statements to be used in federal court, and sworn federal acknowledgments to be used in state court, for these matters.
• Exempts individuals from the evidentiary rule if they were minors at the time of the earlier offense.
• Targets a specific fentanyl analogue (and its analogues) rather than all controlled substances.
• Does not include funding or an effective-date clause in the text provided.
• Raises potential constitutional and evidentiary issues (e.g., hearsay, confrontation, plea dynamics) that courts may need to resolve.